Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.42 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 2/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | CTSH | P09668 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7605775 | 0.93 | MAOA (0.46) | ALDH1A1CYP1A2CYP2D6MAOAMEN1 | |
| SCHEMBL9274171 | 0.93 | MAOA (0.46) | ALDH1A1CYP1A2CYP2D6MAOAMEN1 | |
| SCHEMBL20417941 | 0.89 | ALDH1A1 (0.47) | ALDH1A1CYP1A2CYP2D6MAOAMEN1 | |
| SCHEMBL22052987 | 0.89 | ALDH1A1 (0.47) | ALDH1A1CYP1A2CYP2D6MAOAMEN1 | |
| SCHEMBL8826109 | 0.86 | SIGMAR1 (0.53) | ALDH1A1CYP1A2CYP2D6MAOAMEN1 | |
| SCHEMBL14636033 | 0.86 | MAOA (0.58) | ALDH1A1CYP1A2CYP2D6MAOAMEN1 | |
| SCHEMBL8826112 | 0.86 | SIGMAR1 (0.53) | ALDH1A1CYP1A2CYP2D6MAOAMEN1 | |
| SCHEMBL15873615 | 0.85 | ANPEP (0.44) | ALDH1A1CYP1A2CYP2D6MAOAMEN1 | |
| SCHEMBL9407510 | 0.83 | MEN1 (0.56) | ALDH1A1CYP1A2CYP2D6MAOAMEN1 | |
| SCHEMBL24762812 | 0.82 | MEN1 (0.50) | ALDH1A1CYP1A2CYP2D6MAOAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020193636-A1 | Benzaldehyde reacted with a primary amine to give an imine, which is hydrogenated with hydrogen in the presence of a catalyst and a water miscible solvent | BASF AKTIENGESELLCHAFT (DE) | 2002-12-19 | — | — | US | disclosed |
| US-6476268-B1 | Preparation of N-benzylamines | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-05 | — | — | US | disclosed |
| EP-1247799-A2 | Process for the preparation of N-benzylamines | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193636-A1 | Benzaldehyde reacted with a primary amine to give an imine, which is hydrogenated with hydrogen in the presence of a catalyst and a water miscible solvent | HNMT, INMT, H1-2 | ALDH1A1 247/4885CYP1A2 419/4885CYP2D6 1752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.